Executive Summary
January 23, 2026, saw 196 8-K filings marking a high-volume but predominantly routine day in US equity markets, with neutral sentiment across nearly all disclosures due to sparse quantitative details. Key patterns include a wave of regional bank earnings releases, widespread executive turnover signaling potential leadership instability, frequent unregistered equity sales raising dilution concerns, and a cluster of microcap delistings concentrated in biotech/pharma. Cumulative implications point to microcap distress and SPAC/M&A activity as sector tailwinds, but lack of specifics limits broad market impact; institutional investors should prioritize banking results and monitor delisting cascades for portfolio contagion risks.
Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from January 21, 2026.
Investment Signals(5)
- Regional Banks (e.g., 1ST SOURCE CORP, BancFirst Corp)(BULLISH)β²
Multiple Item 2.02 earnings disclosures amid quiet markets could signal steady performance if exhibits reveal beats on expectations
- GUESS INCβ(BULLISH)β²
Multi-item filing detailing control change, acquisition completion, and delisting suggests transformative going-private event with potential value unlock for shareholders
- LightPath Technologies Incβ(BULLISH)β²
Completion of acquisition (Item 2.01) alongside financing positions company for growth synergies despite dilution risks
Delisting notices indicate severe compliance failures and liquidity distress
- NEXTNRG, INC.β(BEARISH)β²
Termination of material definitive agreement points to strategic setbacks and execution risks
Risk Flags(4)
- Biotech Delistings (KALA BIO, REVIVA PHARMACEUTICALS, Aprea Therapeutics, Nexalin Technology, 60 Degrees Pharmaceuticals)βΌ
Cluster of Item 3.01 notices signals sector-wide microcap distress, potential for forced selling and OTC transition losses
Debt acceleration triggers (Item 2.04) and certifying accountant switches highlight liquidity crunches and governance red flags
- Widespread Equity Dilution (e.g., Interactive Strength, McEwen Inc., Planet Labs PBC)βΌ
Recurring Item 3.02 unregistered sales across small caps amplify shareholder dilution without disclosed offsets
- Officer Turnover Surge (e.g., Analog Devices, Ocular Therapeutix, Lucid Group)βΌ
50+ Item 5.02 filings indicate broad leadership churn, raising execution and stability concerns
Opportunities(4)
- SPAC M&A Pipeline (ASPAC III, EGH Acquisition, Quantumsphere, TLGY Acquisition)β
Multiple Item 1.01 agreements signal de-SPAC catalysts for alpha in merger arbitrage or post-deal pops
- Bank Earnings Digests (Webster Financial, First Citizens Bancshares, Ames National)β
High-materiality Item 2.02 releases offer sector rotation plays if results beat amid stable rates
Control shift and asset disposition create event-driven upside for activists or LBO speculation
- LightPath Technologies Acquisitionβ
Item 2.01 completion with financing unlocks pro forma growth in optics/tech
Sector Themes(3)
- Regional Banking Earnings Cadenceβ
15+ filings (e.g., BancFirst, WesBanco, Northrim Bancorp) reflect quarter-end reporting wave; stable NIMs could bolster financials sector amid rate pause
- Biotech/Pharma Microcap Purgeβ
Delistings (5+ cases) and officer churn correlate with funding droughts, pressuring small-cap health stocks but creating consolidation M&A setups
- SPAC Revival Activityβ
20+ merger/announcement filings (e.g., OneIM, Lake Superior, Bleichroeder) indicate renewed de-SPAC momentum, favoring special purpose vehicles for PIPE/dilution-tolerant plays
Watch List(4)
- π
High-materiality control/delisting event requires full exhibit review for LBO terms and shareholder protections
Item 2.04 debt trigger demands liquidity monitoring for bankruptcy cascade risks
- Regional Banks (e.g., First Citizens, Webster Financial)π
Earnings exhibits critical for NIM/credit quality signals in concentration portfolios
- Biotech Delisters (REVIVA, Nexalin, 60 Degrees)π
Track OTC transitions and activist interventions for short/turnaround opportunities
Filing Analyses(196)
23-01-2026
Interactive Strength, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021272), reporting under Item 3.02 an unregistered sale of equity securities. No quantitative details such as transaction value, share count, parties involved, or financial impacts are disclosed in the provided filing summary. This is a single-item filing focused on a potentially dilutive equity event.
23-01-2026
Diversified Energy Co filed a Form 8-K on January 23, 2026 (AccNo: 0001140361-26-002106, size: 169 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event or exhibits are disclosed in the provided filing summary. Sector not specified.
23-01-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003295, Size: 216 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The sector is not specified. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary.
23-01-2026
Super League Enterprise, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001437749-26-001802), reporting under Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific details on the amendments, disclosures, or exhibits provided in the summary. No numerical values, transaction sizes, or strategic impacts are disclosed.
23-01-2026
DAXOR CORP filed a Form 8-K on 2026-01-23 (AccNo: 0001493152-26-003302, Size: 18 MB) under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative data including transaction values, share counts, percentages, and financial metrics are NOT_DISCLOSED.
23-01-2026
Corvus Pharmaceuticals, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-005968, Size: 550 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of unspecified other events with attached exhibits. No core event details, quantitative data, named entities, or scheduled events are explicitly stated.
23-01-2026
News Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001564708-26-000016, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
23-01-2026
1ST SOURCE CORP filed a Form 8-K on January 23, 2026 (AccNo: 0000034782-26-000004, Size: 906 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure for the US market. No specific financial metrics, transaction details, or numerical values are provided in the filing summary.
23-01-2026
OneIM Acquisition Corp. filed an 8-K on January 23, 2026 (AccNo: 0001213900-26-006879), announcing a Merger/Acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, transaction type, strategic rationale, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
LanzaTech Global, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003163), reporting multiple items including Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Item 5.03), and Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial impacts disclosed in the provided summary. Sector is not specified.
23-01-2026
SYNTEC OPTICS HOLDINGS, INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003285, Size: 275 KB), reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing shareholder vote results and attached exhibits. No details on vote outcomes, matters voted on, or exhibit contents are provided in the summary.
23-01-2026
Forge Global Holdings, Inc. filed a Form 8-K on January 23, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely results from a shareholder meeting. Item 9.01 discloses financial statements and exhibits. No specific vote details, numerical data, or transaction values are provided in the filing summary.
23-01-2026
InnSuites Hospitality Trust filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003274, Size: 228 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary. Sector not specified.
23-01-2026
BancFirst Corp (/OK/) filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-019710, Size: 1 MB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure with no specific numerical financial metrics, transaction details, or guidance provided in the filing summary. Sector is not specified.
23-01-2026
Petco Health & Wellness Company, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-019795, Size: 171 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific core event, transaction details, financial metrics, or scheduled events disclosed in the provided summary. All quantitative data, named entities, and further details are NOT_DISCLOSED.
23-01-2026
The company filed a Form 8-K on January 23, 2026 (AccNo: 0001803498-26-000003, Size: 158 KB), reporting under Items 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). This is a multi-item general filing with no specific transaction details, dollar values, share counts, named entities, or scheduled events disclosed. Sector is not specified.
23-01-2026
COLUMBUS MCKINNON CORP filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020111, Size: 171 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
Materion Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001104657-26-000002, size 177 KB) under Item 2.02 announcing results of operations and financial condition. Sector not specified. No specific financial metrics, transaction details, or scheduled events disclosed in the provided filing summary.
23-01-2026
McEwen Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-005999), reporting unregistered sales of equity securities under Item 3.02. The filing also references Item 9.01 for financial statements and exhibits. No quantitative details, transaction specifics, or additional context are disclosed.
23-01-2026
Booz Allen Hamilton Holding Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003186, Size: 5 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific financial metrics, transaction details, or scheduled events are disclosed in the provided information.
23-01-2026
Franklin Covey Co filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020856), reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Financial Statements and Exhibits). This is a routine disclosure of shareholder meeting vote results with attached exhibits. No specific vote details, numerical values, financial metrics, or scheduled events are disclosed.
23-01-2026
SilverBox Corp V filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006010), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
SLB LIMITED/NV filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020133), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, guidance, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
Ocular Therapeutix, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006015, Size: 188 KB) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. Sector is not specified.
23-01-2026
Analog Devices Inc filed a Form 8-K on January 23, 2026 (AccNo: 0000006281-26-000008, Size: 220 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or other quantitative data are provided.
23-01-2026
Axogen, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0000805928-26-000026, Size: 655 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core event, transaction value, financial impacts, or named entities disclosed in the provided summary. All quantitative data, scheduled events, and further context are NOT_DISCLOSED.
23-01-2026
Datavault AI Inc. filed an 8-K on January 23, 2026 (AccNo: 0001104659-26-006014), disclosing under Item 2.01 the completion of an acquisition or disposition of assets, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on parties involved, deal structure, valuation, consideration, or financial metrics are disclosed. Sector is not specified.
23-01-2026
Lantern Pharma Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003314, Size: 16 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of potentially material information and attached exhibits. No core event details, financial metrics, transaction values, or scheduled events are disclosed in the provided filing summary.
23-01-2026
Webster Financial Corp filed an 8-K on January 23, 2026 (AccNo: 0000801337-26-000004), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or scheduled events are mentioned.
23-01-2026
Sanara MedTech Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003316, Size: 262 KB) under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US SEC with sector not specified. No numerical financial metrics, transaction details, named entities beyond the filer, or scheduled events are explicitly stated.
23-01-2026
ETHZilla Corp filed an 8-K on January 23, 2026 (AccNo: 0001213900-26-006924) disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides financial statements and exhibits related to the transaction. No details on parties involved, deal structure, valuation, or strategic rationale are specified.
23-01-2026
Massimo Group filed a Form 8-K on 2026-01-23 (AccNo: 0001493152-26-003318, Size: 201 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any named individuals are provided in the filing summary. Sector is not specified, and no quantitative data, scheduled events, or further governance implications are disclosed.
23-01-2026
NeoVolta Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001683168-26-000482), reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing for Items 1.01 and 2.02, with voluntary Item 7.01. No specific details on the agreement, transaction values, financial metrics, or impacts are disclosed in the provided information.
23-01-2026
Matador Resources Co filed a Form 8-K on 2026-01-23 (AccNo: 0001628280-26-003190, Size: 205 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason, or compensation provided.
23-01-2026
ASPAC III Acquisition Corp. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-006925, Size: 246 KB) under Item 3.02 disclosing unregistered sales of equity securities in connection with a merger/acquisition event. No details on parties involved, deal structure, valuation, consideration, synergies, regulatory pathway, shareholder impact, or sector implications are provided. Sector is not specified.
23-01-2026
NextCure, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006021, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific quantitative data, transaction details, or scheduled events are disclosed in the provided filing summary.
23-01-2026
Tron Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003321), reporting under Item 7.01 Regulation FD Disclosure. No details on the core event, financial impacts, transactions, or scheduled events are explicitly stated in the provided filing summary. Sector not specified.
23-01-2026
Ocugen, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006031), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure with no specific event details, transaction values, or financial metrics provided in the summary. No quantitative data, named entities, or scheduled events are mentioned.
23-01-2026
Webster Financial Corp filed an 8-K on January 23, 2026 (AccNo: 0000801337-26-000006, Size: 1 MB), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other quantitative data are mentioned.
23-01-2026
Bed Bath & Beyond, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001130713-26-000010, Size: 13 MB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were filed. No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or any quantitative data are disclosed.
23-01-2026
Acadia Healthcare Company, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001193125-26-020169, Size: 233 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or individuals involved are disclosed. Sector not specified.
23-01-2026
Lendway, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006044), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, obligation, dollar values, counterparties, or other quantitative data disclosed in the provided summary. Sector is not specified.
23-01-2026
Lake Superior Acquisition Corp filed an 8-K on 2026-01-23 (AccNo: 0001477932-26-000348, Size: 237 KB) announcing a Merger/Acquisition under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific deal structure, parties, valuation, financial metrics, or strategic details are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
GUESS INC filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-020386) disclosing multiple material events including entry into and termination of a material definitive agreement (Items 1.01, 1.02), completion of acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of registrant (Item 5.01), and changes in directors/officers including compensatory arrangements (Item 5.02). These disclosures suggest a significant corporate transaction such as a merger, acquisition, or going-private event leading to delisting and control change. No specific parties, deal values, or financial metrics are disclosed.
23-01-2026
EGH Acquisition Corp. filed an 8-K on January 23, 2026 (AccNo: 0001104659-26-006046, Size: 2 MB), disclosing under Item 1.01 Entry into a Material Definitive Agreement related to a Merger/Acquisition event, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on parties, structure, valuation, or other deal terms are provided in the filing summary. Sector is not specified.
23-01-2026
QT Imaging Holdings, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003206, Size: 903 KB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction values, parties involved, or financial impacts disclosed in the provided summary. Sector is not specified.
23-01-2026
WesBanco Inc filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-020368), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the summary. Sector is not specified.
23-01-2026
The company filed an 8-K on January 23, 2026 (AccNo: 0001826000-26-000015, Size: 190 KB) under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US SEC source. No specific financial metrics, transaction details, or named entities are mentioned in the provided filing excerpt.
23-01-2026
PodcastOne, Inc. filed an 8-K on January 23, 2026 (AccNo: 0001213900-26-006946), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific numerical financial metrics, transaction values, or other quantitative data are disclosed in the provided filing summary.
23-01-2026
Plumas Bancorp filed an 8-K on 2026-01-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). AccNo: 0001437749-26-001817, file size 165 KB. No specific details on the officer position, appointment/resignation, reasons, or compensation provided in the available information.
23-01-2026
Gencor Industries Inc filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020473, size 135 KB), reporting under Item 5.08 regarding Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 and Item 8.01 for Other Events. No specific details, transaction values, financial metrics, named individuals, or scheduled events are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
NEXTNRG, INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003324, Size: 219 KB), reporting under Item 1.02 the termination of a material definitive agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, dollar values, or financial impacts provided in the summary. Sector not specified.
23-01-2026
BV Financial, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0000943374-26-000014, Size: 296 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual names, appointment/resignation status, reasons, or timing are provided in the filing summary. Sector is not specified.
23-01-2026
Northrim BanCorp Inc filed an 8-K on January 23, 2026 (AccNo: 0001163370-26-000004, Size: 1 MB) reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. This is a financial results disclosure from the US SEC. No specific financial metrics, transaction details, or scheduled events are mentioned.
23-01-2026
Company filed Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006102), disclosing Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No details on the specific agreement, transaction terms, parties involved, financial impacts, or exhibits are provided in the excerpt. Analysis is severely limited by absence of filing content beyond item headers.
23-01-2026
Company filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006120, Size: 53 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Event type classified as General Filing from US SEC source.
23-01-2026
C & F FINANCIAL CORP filed an 8-K on 2026-01-23 (AccNo: 0000913341-26-000003, Size: 170 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's name, title, reason for change, or exhibits are provided in the summary. Sector not specified.
23-01-2026
SEC filing dated January 23, 2026 (AccNo: 0001493152-26-003332, Size: 297 KB) discloses a Merger/Acquisition event with Item 1.01 Entry into a Material Definitive Agreement, Item 5.03 Amendments to Articles of Incorporation or Bylaws or Change in Fiscal Year, Item 5.07 Submission of Matters to a Vote of Security Holders, and Item 9.01 Financial Statements and Exhibits. No specific parties, deal structure, valuation, transaction value, share counts, percentages, financial metrics, named entities, or scheduled events are mentioned. All quantitative and qualitative deal details are NOT_DISCLOSED.
23-01-2026
Planet Labs PBC filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020587), reporting Item 3.02 (Unregistered Sales of Equity Securities), Item 3.03 (Material Modifications to Rights of Security Holders), and Item 8.01 (Other Events). This is a multi-item filing with no specific transaction details, dollar values, share counts, or financial metrics disclosed. Core events involve equity securities sales and rights modifications, but all quantitative data is NOT_DISCLOSED.
23-01-2026
Company filed an 8-K on 2026-01-23 (AccNo: 0001829126-26-000478, Size: 188 KB) under Item 5.02 disclosing an officer change event dated January 23, 2026. Event type is Officer Change related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on officer name, position, appointment/resignation, reasons, or impacts are disclosed in the provided filing summary.
23-01-2026
Westamerica Bancorporation filed an 8-K on 2026-01-23 (AccNo: 0001171843-26-000400, Size: 187 KB) disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or quantitative data are provided in the filing summary. Event classified as Officer Change; sector not specified.
23-01-2026
SB Financial Group, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007034, Size: 218 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary Regulation FD disclosure with attached exhibits. No core event details, financial metrics, transaction values, or scheduled events are specified in the provided filing summary.
23-01-2026
The registrant filed a Form 8-K on 2026-01-23 (AccNo: 0001331463-26-000012, Size: 172 KB) under Item 2.03 disclosing the creation of a direct financial obligation or off-balance sheet arrangement via a Credit Agreement dated January 23, 2026. This is a single-item mandatory disclosure event type 'Credit Agreement' from US SEC source. No dollar values, terms, counterparties, or other specifics are mentioned in the provided filing excerpt.
23-01-2026
PROVIDENT FINANCIAL HOLDINGS INC filed a Form 8-K on January 23, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The filing has Accession Number 0000939057-26-000014 and size of 216 KB. No specific details on the events, transactions, financials, or exhibits are disclosed in the provided summary.
23-01-2026
Unidentified company filed an 8-K on 2026-01-23 (AccNo: 0001213900-26-007067, Size: 268 KB) under Items 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), signaling an officer change event dated January 23, 2026. No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or departure, reasons, named individuals, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
TriLinc Global Impact Fund LLC filed a Form 8-K on January 23, 2026 (AccNo: 0001437749-26-001837, Size: 145 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impact, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
BJ's Restaurants Inc. filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-020736, Size: 207 KB) disclosing an Item 5.02 event involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided in the available information. Sector not specified.
23-01-2026
Centrus Energy Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003245, Size: 1 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
PROVIDENT FINANCIAL HOLDINGS INC filed a Form 8-K on January 23, 2026 (AccNo: 0000939057-26-000016, Size: 214 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, financial statements, or exhibits are disclosed in the provided filing summary. All transaction values, financial metrics, and strategic implications are NOT_DISCLOSED.
23-01-2026
C2 Blockchain, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001882781-26-000003, Size: 196 KB), reporting Item 3.02 (Unregistered Sales of Equity Securities), Item 5.01 (Changes in Control of Registrant), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing indicating material events related to equity sales and control changes, but no transaction details, values, or quantitative data are disclosed. Sector is not specified.
23-01-2026
Company filed an 8-K on January 23, 2026 (AccNo: 0001331451-26-000014, Size: 336 KB) disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. Event type is Financial Results from US SEC source. No specific financial metrics, transaction details, named entities, or scheduled events are provided in the filing summary.
23-01-2026
Goldman Sachs Group Inc filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020895, Size: 273 KB) under Item 8.01 Other Events. No details on the specific event, transaction, financial impacts, or quantitative data are disclosed in the filing summary. Sector not specified.
23-01-2026
This 8-K filing, dated January 23, 2026 (AccNo: 0001104659-26-006211, 86 KB), reports under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. Sector not specified.
23-01-2026
The company filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020910, Size: 2 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing as Item 1.01 triggers required disclosure within 4 business days. No specific details on the agreement, events, transaction value, parties, or financial impacts are disclosed in the provided filing summary.
23-01-2026
Company filed 8-K on 2026-01-23 (AccNo: 0001193125-26-020905) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 2.03 Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement. Item 9.01 discloses Financial Statements and Exhibits. No specific transaction details, values, parties, or terms provided.
23-01-2026
Company filed Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006208, Size: 2 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event, but specific details of the agreement, events, or exhibits are NOT_DISCLOSED. No quantitative data, named entities, or scheduled events are mentioned.
23-01-2026
Next Technology Holding Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007151, Size: 232 KB), reporting changes in its certifying accountant under Item 4.01 and including financial statements and exhibits under Item 9.01. No specific details on the auditor change, reasons, financial metrics, or transaction values are disclosed in the provided filing summary. This is a mandatory disclosure for a potentially material event.
23-01-2026
BV Financial, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020952), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, percentages, or other quantitative data are disclosed in the filing summary. This is a standard financial results disclosure with no details on earnings, guidance, or scheduled events provided.
23-01-2026
FG Imperii Acquisition Corp. filed an 8-K on January 23, 2026 (AccNo: 0001104659-26-006213), disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific parties, deal structure, valuation, synergies, or quantitative terms are disclosed in the provided filing summary. Sector not specified.
23-01-2026
The company filed an 8-K on 2026-01-23 (AccNo: 0001829126-26-000489, Size: 187 KB) under Item 5.02 disclosing an officer change event dated January 23, 2026. No specific details provided on the officer's name, position (e.g., CEO, CFO), nature of change (appointment, resignation, or compensatory arrangement), reason, or any quantitative data. Sector not specified.
23-01-2026
The company filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006207, Size: 3 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item material event disclosure with no specific details provided on the agreement, events, transaction value, or financial impacts. Sector is not specified.
23-01-2026
YUNHONG GREEN CTI LTD. filed a Form 8-K on 2026-01-23 (AccNo: 0001493152-26-003370, Size: 196 KB) disclosing an event under Item 5.02. The item covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on individuals, positions, reasons, or arrangements are explicitly stated.
23-01-2026
AMES National Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001437749-26-001905), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results in the US equity markets from us_sec source. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary.
23-01-2026
Bleichroeder Acquisition Corp. II filed an 8-K on January 23, 2026 (AccNo: 0001213900-26-007203, Size: 261 KB) announcing a Merger/Acquisition event under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, strategic rationale, or quantitative metrics such as transaction value, share counts, or percentages are disclosed. Sector is not specified.
23-01-2026
VisionWave Holdings, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001731122-26-000106, Size: 644 KB) reporting a Material Event under Item 1.01 for Entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with no specific details provided on the agreement, transaction terms, parties involved, or financial impacts. Sector is not specified.
23-01-2026
Bausch Health Companies Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0000885590-26-000008, Size: 161 KB) under Item 7.01 for Regulation FD Disclosure. No specific details on the disclosure content, events, transactions, or financial metrics are provided in the filing summary. This is a voluntary disclosure of material nonpublic information.
23-01-2026
La Rosa Holdings Corp. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007194, Size: 228 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results. No quantitative data, transaction details, or scheduled events are disclosed in the provided information.
23-01-2026
ZYNEX INC filed a Form 8-K on 2026-01-23 (AccNo: 0001104659-26-006240) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
23-01-2026
Century Therapeutics, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006236), reporting under Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 8.01 (Other Events). This is a multi-item filing with no specific details on votes, events, transactions, or quantitative data disclosed in the provided summary. Sector not specified.
23-01-2026
LightPath Technologies Inc filed an 8-K on 2026-01-23 (AccNo: 0001437749-26-001904, Size: 1 MB) disclosing a merger/acquisition event with Item 1.01 (Entry into Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 2.03 (Creation of Direct Financial Obligation), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Specific details including parties involved, deal structure, valuation, transaction type, strategic rationale, and quantitative metrics are NOT_DISCLOSED. Sector not specified.
23-01-2026
Verses AI Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003376, Size: 218 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
Ondas Holdings Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007197), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or quantitative impacts disclosed in the provided information. Sector not specified.
23-01-2026
International Paper Co (/NEW/) filed an 8-K on January 23, 2026 (AccNo: 0001628280-26-003279), disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on parties involved, deal structure, valuation, target, or financial metrics are mentioned.
23-01-2026
Block, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021035, Size: 137 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or quantitative data are provided. Sector is not specified, and no scheduled events or financial metrics are mentioned.
23-01-2026
SharonAI Holdings, Inc. filed Form 8-K on 2026-01-23 (AccNo: 0001829126-26-000505, Size: 765 KB) reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), departure/election/appointment of directors or certain officers including compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing covering material events. No specific transaction details, values, names, or financial metrics are disclosed.
23-01-2026
XCel Brands, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006234), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided summary. Sector is not specified.
23-01-2026
Soligenix, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006233, Size: 568 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
23-01-2026
Barfresh Food Group Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003375, Size: 198 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment/resignation status, reasons, or compensation are provided in the summary. Sector is not specified.
23-01-2026
Jones Soda Co filed a Form 8-K on 2026-01-23 (AccNo: 0001493152-26-003378, size: 196 KB) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 1.02 Termination of a Material Definitive Agreement. This is a multi-item filing with no details provided on the agreements, parties, transaction values, or financial impacts. Sector not specified.
23-01-2026
Quantumsphere Acquisition Corp, a SPAC-like entity, filed an 8-K on 2026-01-23 (AccNo: 0001829126-26-000503, Size: 298 KB) disclosing Item 1.01 Entry into a Material Definitive Agreement related to a Merger/Acquisition event and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, consideration type, strategic rationale, regulatory pathway, shareholder impact, or quantitative metrics such as transaction value, share counts, or percentages are disclosed in the provided filing summary. Sector not specified; analysis limited to filing items only.
23-01-2026
The company filed a Form 8-K on January 23, 2026 (AccNo: 0002049733-26-000003, Size: 25 KB) disclosing Item 3.02 regarding unregistered sales of equity securities. No specific details on the transaction, such as value, share count, parties involved, or strategic context, are provided in the filing summary. This appears to be a mandatory single-item disclosure under SEC requirements for such events.
23-01-2026
KALA BIO, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001829126-26-000502) under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No additional details on the delisting reason, financial impacts, or transaction values are provided in the available information. Sector not specified.
23-01-2026
Lucid Group, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001628280-26-003278, Size: 159 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.
23-01-2026
Blue Owl Technology Finance Corp. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003277, Size: 755 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, events, transaction values, or financial impacts are disclosed in the provided filing summary. Sector not specified.
23-01-2026
Astria Therapeutics, Inc. filed an 8-K on January 23, 2026 (AccNo: 0001104659-26-006228, Size: 353 KB), disclosing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), notice of delisting (Item 3.01), material modifications to security holders' rights (Item 3.03), changes in control (Item 5.01), director/officer changes (Item 5.02), amendments to articles/bylaws (Item 5.03), and financial statements (Item 9.01). This indicates a significant merger/acquisition event for the company, likely positioning Astria as the target given delisting and control change triggers. No specific parties, deal structure, valuation, or financial metrics are disclosed.
23-01-2026
Two Hands Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001494413-26-000004, Size: 5 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing as a material event. No transaction details, dollar values, or other quantitative data disclosed.
23-01-2026
AAR CORP filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006227, Size: 250 KB) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are provided in the available information. Sector is not specified.
23-01-2026
Marpai, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001213900-26-007191, Size: 191 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, compensation, or other quantitative data are provided in the summary. Sector is not specified.
23-01-2026
Voya Financial, Inc. filed a General Filing (Form 8-K) on January 23, 2026, under Item 7.01 Regulation FD Disclosure. Accession Number: 0001535929-26-000005, file size 179 KB. No specific details on the disclosure content, transaction values, or events are provided in the filing summary.
23-01-2026
Abpro Holdings, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007215), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, named parties, or quantitative impacts disclosed. Sector not specified.
23-01-2026
Bluerock Acquisition Corp. filed an 8-K on 2026-01-23 (AccNo: 0001213900-26-007216, Size: 304 KB) disclosing Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers, and Item 9.01: Financial Statements and Exhibits. No merger, acquisition, transaction details, parties, valuations, or quantitative data are mentioned. Sector not specified.
23-01-2026
Acuity Inc. (DE) filed a Form 8-K on January 23, 2026 (AccNo: 0001144215-26-000015), reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, vote outcomes, numerical data, or related entities are disclosed in the filing summary. This is a single-item mandatory disclosure typically related to shareholder meeting results.
23-01-2026
NexPoint Real Estate Finance, Inc. filed an 8-K on 2026-01-23 (AccNo: 0001437749-26-001916, Size: 177 KB) reporting Item 1.01: Entry into a Material Definitive Agreement. No details on the agreement's parties, terms, value, or financial impact are provided in the summary. Sector not specified.
23-01-2026
Company filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006243, Size: 184 KB) under Item 8.01 Other Events, classified as a General Filing event type. No specific details on the core event, transaction, financial impacts, or other material information are disclosed in the provided filing summary. Sector not specified.
23-01-2026
Health Catalyst, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001636422-26-000010, Size: 170 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer involved, nature of change (appointment or resignation), reasons, or compensation are provided in the summary. Sector is not specified.
23-01-2026
Elme Communities filed a Form 8-K on January 23, 2026 (AccNo: 0000104894-26-000004, Size: 530 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or any quantitative data are provided in the filing summary. Sector not specified.
23-01-2026
JFB Construction Holdings filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003384, Size: 327 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer position, appointment/resignation, reasons, or compensation are provided.
23-01-2026
Lake Shore Bancorp, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021063), reporting an 'Other Event' under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details of the event, transaction values, financial impacts, or other quantitative data are disclosed in the provided filing summary. This is a multi-item filing with sector not specified.
23-01-2026
RXO, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0000950142-26-000221, Size: 187 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the available information. Sector is not specified.
23-01-2026
REVIVA PHARMACEUTICALS HOLDINGS, INC. filed an 8-K on 2026-01-23 (AccNo: 0001437749-26-001913, size 179 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, and under Item 8.01 Other Events. This indicates a delisting event from the US market, but no further details on reasons, financial impacts, or transaction values are disclosed.
23-01-2026
Vivakor, Inc. filed a Form 8-K on 2026-01-23 disclosing unregistered sales of equity securities under Item 3.02. Accession number: 0001829126-26-000507; file size: 189 KB. No transaction details, financial metrics, or other specifics provided.
23-01-2026
The company filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-021132) reporting under Items 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). This is a multi-item general filing with no specific transaction details, dollar values, share counts, or financial metrics disclosed. No named entities, scheduled events, or quantitative data are mentioned.
23-01-2026
Jaguar Health, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001193125-26-021064) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, share counts, or other numerical data disclosed in the provided summary. All core event details such as agreement terms, parties, or financial impacts are NOT_DISCLOSED.
23-01-2026
Enphase Energy, Inc. filed a Form 8-K on January 23, 2026, under Item 7.01 for Regulation FD Disclosure. The filing has Accession Number 0001463101-26-000005 and a file size of 210 KB. No specific details on the content of the Regulation FD disclosure are provided in the summary.
23-01-2026
BitGo Holdings, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003294, Size: 530 KB), reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in Fiscal Year. Item 9.01 discloses financial statements and exhibits. No specific details on the amendments, quantitative data, transaction values, or scheduled events are provided in the filing summary.
23-01-2026
The company filed a Form 8-K on January 23, 2026, reporting under Item 8.01 Other Events (AccNo: 0001521945-26-000004, size 162 KB). No specific details on the event, transaction, financial impacts, or scheduled events are disclosed in the provided filing information. Sector is not specified.
23-01-2026
Wells Fargo & Company/MN filed a General Filing (likely Form 8-K) on January 23, 2026, under Item 9.01 Financial Statements and Exhibits. Accession Number: 0001193125-26-021049, file size 729 KB. No specific details on financial statements, exhibits, transactions, or events are disclosed in the provided filing summary.
23-01-2026
Six Flags Entertainment Corporation filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021051, Size: 150 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts disclosed in the provided information. Sector is not specified.
23-01-2026
PetMed Express Inc filed a Form 8-K on January 23, 2026 (AccNo: 0001040130-26-000002, 198 KB), reporting under Item 5.07 the submission of matters to a vote of security holders. No specific vote outcomes, numerical data, or additional details are disclosed in the provided filing summary. This appears to be a standard post-shareholder meeting disclosure.
23-01-2026
Ryder System Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003301, Size: 140 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer's name, position, appointment/resignation status, reasons, or quantitative data are provided.
23-01-2026
Company filed Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021081), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event, but specific details on the agreement, obligation, transaction value, parties, or exhibits are NOT_DISCLOSED in the provided information. No quantitative data, named entities, or scheduled events are mentioned.
23-01-2026
Cerus Corp (CERUS) filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-021085, Size: 141 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment/resignation status, reasons, or timing are provided. Sector is not specified.
23-01-2026
Jabil Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021086, Size: 582 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, transaction value, or financial impacts disclosed in the provided summary. Sector not specified.
23-01-2026
The company filed a Form 8-K on January 23, 2026, under Item 8.01 Other Events, classified as a General Filing with Accession Number 0001140361-26-002209 and file size of 147 KB. No specific details regarding the event, transaction, or any financial metrics are disclosed in the provided filing information. Sector is not specified.
23-01-2026
GAXOS.AI INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007257, Size: 492 KB) reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided summary. Sector not specified.
23-01-2026
Company filed an 8-K on 2026-01-23 (AccNo: 0001493152-26-003419, Size: 199 KB) under Item 5.02 disclosing an officer change event dated January 23, 2026. Event type is specified as 'Officer Change' with no further details on position, individual, appointment/resignation, or reasons provided. Sector not specified; no quantitative data, named entities, or scheduled events mentioned.
23-01-2026
Trailblazer Merger Corp I, a likely SPAC, filed an 8-K on 2026-01-23 (AccNo: 0001213900-26-007230, Size: 256 KB) under Item 5.02 disclosing departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No details on any merger/acquisition, parties, valuation, or strategic rationale are mentioned. Sector not specified.
23-01-2026
Murphy Oil Corp filed a Form 8-K on January 23, 2026 (AccNo: 0000950103-26-000906, Size: 699 KB), reporting under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. The filing also discloses other events under Item 8.01 and includes financial statements and exhibits under Item 9.01. No specific details on the transaction, dollar values, or other quantitative data are provided in the filing summary.
23-01-2026
Biocryst Pharmaceuticals Inc filed a Form 8-K on January 23, 2026 (AccNo: 0001171843-26-000405, Size: 189 KB), disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or compensatory terms are stated. Sector not specified.
23-01-2026
ProCap Financial, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003410, Size: 256 KB) disclosing an officer change under Item 5.02. Item 5.02 covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the officer, position, reason for change, or other impacts are provided; sector is not specified.
23-01-2026
Algorhythm Holdings, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003407, Size: 199 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or scheduled events are disclosed in the provided filing summary. Sector not specified.
23-01-2026
PAVmed Inc. filed a Form 8-K on January 23, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative data, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.
23-01-2026
Battalion Oil Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006252), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details, transaction values, or quantitative data disclosed in the provided summary. Sector is not specified.
23-01-2026
INNO HOLDINGS INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003411, Size: 462 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, financial impacts, or strategic rationale are disclosed in the provided information. Sector is not specified.
23-01-2026
NEW JERSEY RESOURCES CORP filed a Form 8-K on January 23, 2026 (AccNo: 0001140361-26-002201, Size: 176 KB), reporting under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific details on officer changes, voting outcomes, or exhibits are disclosed in the provided summary. Event classified as Officer Change from US SEC source.
23-01-2026
BIOCRYST PHARMACEUTICALS INC filed an 8-K on 2026-01-23 (AccNo: 0001140361-26-002200, Size: 2 MB) disclosing a Merger/Acquisition event with Item 1.01 (Entry into a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on parties involved, deal structure, valuation, or quantitative metrics are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
Collab Z Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007244, Size: 601 KB), reporting multiple items: 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction values, parties involved, or financial impacts provided in the summary. Sector is not specified.
23-01-2026
Cathay General Bancorp filed a Form 8-K on January 23, 2026 (AccNo: 0001437749-26-001931), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED in the provided filing summary. No quantitative data, scheduled events, or financial metrics are mentioned.
23-01-2026
Capitol Federal Financial, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001490906-26-000002, Size: 209 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or specific financial statements/exhibits are provided. Sector not specified.
23-01-2026
Chain Bridge Bancorp Inc filed an 8-K on January 23, 2026 (AccNo: 0001628280-26-003313, Size: 144 KB) disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on the affected officers, reasons for change, or compensatory terms are provided in the available information. Sector is not specified.
23-01-2026
Primerica, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021183, Size: 206 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the summary. Sector is not specified.
23-01-2026
Bain Capital Specialty Finance, Inc. filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-021189), reporting entry into a Material Definitive Agreement under Item 1.01 and including Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts disclosed in the provided information. Sector not specified.
23-01-2026
Aprea Therapeutics, Inc. filed a Form 8-K on 2026-01-23 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No specific reasons, financial impacts, transaction values, or other details are disclosed in the provided summary. Filing Accession Number: 0001104659-26-006267, size: 191 KB.
23-01-2026
FIRST CAPITAL INC filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006268, Size: 873 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing for financial results disclosure. No specific financial metrics, transaction details, or scheduled events are mentioned in the provided filing summary.
23-01-2026
Presidio Property Trust, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003424, Size: 265 KB), reporting under Item 2.04 a triggering event that accelerates or increases a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific details on the core event, transaction value, financial impacts, or related entities are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
374Water Inc. disclosed an officer change via SEC Form 8-K filed on January 23, 2026 (AccNo: 0001654954-26-000569, Size: 136 KB). The filing pertains to Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or quantitative data are disclosed in the provided filing summary.
23-01-2026
NU RIDE INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003436, Size: 190 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 8.01 Other Events. No details on the agreement, transaction size, or events are disclosed in the provided summary. Sector is not specified.
23-01-2026
Company filed an 8-K under Item 7.01 Regulation FD Disclosure on January 23, 2026 (AccNo: 0001193125-26-021206, Size: 560 KB). This is a voluntary general filing with no specific details on the core event, transaction, financial impacts, or other material information disclosed in the provided summary. Sector not specified.
23-01-2026
RLI CORP filed a Form 8-K on January 23, 2026 (AccNo: 0000084246-26-000002, Size: 312 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the core event, transaction value, financial impacts, or exhibits content are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure under Regulation FD.
23-01-2026
Form 8-K filed January 23, 2026 (AccNo: 0000929638-26-000243, Size: 3 MB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item Material Event filing from an unspecified company and sector. No details on the agreement, events, transaction value, or exhibits are disclosed.
23-01-2026
Pacific Oak Strategic Opportunity REIT, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001452936-26-000007, Size: 155 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. This is a multi-item filing with no specific transaction values, names, or financial details disclosed in the summary. Sector is not specified.
23-01-2026
Unnamed company filed an 8-K on 2026-01-23 (AccNo: 0001193125-26-021244, Size: 225 KB) reporting Items 2.02 (Results of Operations and Financial Condition), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Event type is Financial Results from US SEC source. No specific financial metrics, transaction details, company name, sector, or quantitative data disclosed in the provided information.
23-01-2026
FuboTV Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003429, size: 282 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
23-01-2026
Matinas BioPharma Holdings, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003445, Size: 209 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or quantitative data are provided in the filing summary. Sector is not specified.
23-01-2026
Nuwellis, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001140361-26-002241, Size: 201 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or any quantitative data are explicitly stated. Event type is Officer Change; sector not specified.
23-01-2026
BlackRock TCP Capital Corp. filed a Form 8-K on January 23, 2026, under Item 8.01 Other Events. No specific details of the event, transaction values, financial impacts, or scheduled events are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
NVIDIA Corp disclosed an officer change via Form 8-K filed on January 23, 2026 (AccNo: 0001045810-26-000003, Size: 133 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons, or quantitative data are provided in the filing summary. Sector is not specified.
23-01-2026
Company filed a Form 8-K on 2026-01-23 (AccNo: 0001193125-26-021228) reporting Items 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). This is a multi-item general filing with no specific transaction details, dollar values, or event descriptions provided. Sector not specified.
23-01-2026
This Form 8-K filing under Item 4.01 reports changes in the registrant's certifying accountant, filed on January 23, 2026, with Accession Number 0001213900-26-007298 and file size 184 KB. No merger or acquisition details, parties, valuations, or strategic rationale are disclosed. Sector is not specified.
23-01-2026
Q/C TECHNOLOGIES, INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003440), reporting a multi-item disclosure under Items 1.01 (Entry into a Material Definitive Agreement), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, personnel changes, events, transaction values, financial metrics, or named entities are disclosed in the provided summary. All quantitative data, dollar values, share counts, and scheduled events are NOT_DISCLOSED.
23-01-2026
Conduent Inc filed a Form 8-K on January 23, 2026 (AccNo: 0001140361-26-002237), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer's name, title (e.g., CEO, CFO), appointment/resignation status, reasons, or timing are disclosed in the provided information. No quantitative data, named individuals, or scheduled events are mentioned.
23-01-2026
Modular Medical, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001213900-26-007296, Size: 1 MB) reporting under Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 5.07 (Submission of Matters to a Vote of Security Holders), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific event details, transaction values, or numerical data disclosed in the summary. Sector not specified.
23-01-2026
Lottery.com Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003455, Size: 264 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impact, or scheduled events are disclosed in the provided filing summary. Sector not specified.
23-01-2026
Teleflex Inc. disclosed an officer change via Form 8-K filed on January 23, 2026 (AccNo: 0000096943-26-000006, Size: 141 KB) under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation, reasons, or quantitative data are provided in the filing summary. Sector is not specified.
23-01-2026
QHSLab, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003438), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided information. Sector is not specified.
23-01-2026
Soleno Therapeutics Inc filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021229, Size: 298 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the filing summary. Sector is not specified.
23-01-2026
Community Bancorp /VT filed a Form 8-K on January 23, 2026 (AccNo: 0001654954-26-000571, size 303 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or scheduled events are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
Intel Corp filed a Form 8-K on January 23, 2026 (AccNo: 0000050863-26-000031), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, financial statements, or exhibits are provided in the filing summary. All quantitative data, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.
23-01-2026
Spring Valley Acquisition Corp. III filed an 8-K on January 23, 2026 (AccNo: 0001104659-26-006283), disclosing under Item 1.01 entry into a Material Definitive Agreement related to a Merger/Acquisition event. Item 3.02 covers Unregistered Sales of Equity Securities, and Item 9.01 provides Financial Statements and Exhibits. No specific details on parties, deal structure, valuation, or quantitative metrics are disclosed.
23-01-2026
ProPhase Labs, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003456, Size: 893 KB), reporting a multi-item disclosure under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No details on the core transaction, parties, dollar value, share counts, or financial impacts are explicitly stated in the provided filing summary. This is a mandatory disclosure triggered by material events.
23-01-2026
Ovintiv Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021275), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of material information via Regulation FD with attached exhibits. No specific details on events, transactions, financial metrics, or scheduled events are provided in the filing summary.
23-01-2026
Company filed Form 8-K on 2026-01-23 (AccNo: 0000921825-26-000003) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Obligation under an Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing classified as a Material Event. No specific details on the core event, transaction value, parties, financial impacts, or scheduled events are disclosed.
23-01-2026
KB Home filed a Form 8-K on January 23, 2026 (AccNo: 0000795266-26-000019, Size: 186 KB), disclosing Item 5.02 regarding the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for changes, or quantitative data are provided in the available information. Sector is not specified.
23-01-2026
Coherus Oncology, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006307, Size: 231 KB), disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.
23-01-2026
Nexalin Technology, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001829126-26-000513, Size: 255 KB), reporting under Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This indicates a delisting event from the US market. No specific details on delisting reasons, financial impacts, transaction values, or other quantitative data are disclosed in the provided information.
23-01-2026
Clearwater Analytics Holdings, Inc. filed a Form 8-K on January 23, 2026, under Item 8.01 Other Events, with accession number 0001193125-26-021289 and file size of 152 KB. This is a single-item filing reporting an unspecified other event. No details on the core event, financial impacts, transaction values, or quantitative data are disclosed in the provided filing summary.
23-01-2026
TLGY Acquisition Corp filed an 8-K on January 23, 2026 (AccNo: 0001213900-26-007343), disclosing under Item 1.01 entry into a Material Definitive Agreement, indicative of a merger or acquisition event. Item 9.01 covers Financial Statements and Exhibits. No specific details on parties, deal structure, valuation, or sector provided.
23-01-2026
Zoomcar Holdings, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007349, Size: 6 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event, transaction details, financial metrics, or scheduled events are specified in the provided filing summary. This appears to be a multi-item voluntary disclosure compliant with Regulation FD timing requirements.
23-01-2026
60 Degrees Pharmaceuticals, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007330, Size: 240 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, indicating delisting from the US market. Item 7.01 covers Regulation FD Disclosure. No quantitative data, financial impacts, or specific reasons for delisting are disclosed in the provided information.
23-01-2026
ProPhase Labs, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003460, Size: 215 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financials, or exhibits are disclosed in the provided filing summary. Sector not specified.
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 196 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC